Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Data from Phase 3 Studies of Investigational Fixed-Dose Combination of Azilsartan Medoxomil Plus Chlorthalidone Presented at the American Society of Hypertension Annual Scientific Meeting
5/23/2011 8:37:30 AM
More...
|
Relypsa, Inc. Announces Presentation of Positive Phase 2 Results for RLY5016 at American Society of Hypertension Meeting
5/23/2011 7:15:37 AM
More...
|
Cylene Pharmaceuticals, Inc. Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hypertension Meeting
12/6/2010 7:59:54 AM
More...
|
Analyses Of Phase 3 Blood Pressure Data For NicOx SA (NCOX.F)'s Naproxcinod Presented At American Society of Hypertension
5/7/2009 11:24:37 AM
More...
|
Cytokine PharmaSciences Presents Non-Clinical Data From Its Smooth Muscle Contractility Program at the American Society of Hypertension 24th Annual Scientific Meeting and Exposition
5/7/2009 11:02:37 AM
More...
|
Cytokinetics, Inc. (CYTK) Announces Non-Clinical Data Relating to Its Smooth Muscle Contractility Program to Be Presented at the American Society of Hypertension 24th Annual Scientific Meeting and Exposition
5/4/2009 11:34:14 AM
More...
|
New Study In American Society of Hypertension Journal Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
6/16/2008 11:51:41 AM
More...
|
Daiichi Sankyo Co Ltd. New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) Data Presented at the American Society of Hypertension's Twenty-Third Annual Scientific Meeting
5/14/2008 7:32:48 AM
More...
|
American Society of Hypertension Partners with iMedicor
1/14/2008 9:09:21 AM
More...
|
Forest Laboratories, Inc. (FRX) Data Presented at American Society of Hypertension Demonstrate Nebivolol Lowers Blood Pressure as Long-Term Monotherapy and in Combination Therapy
5/21/2007 2:26:57 PM
More...
|
|